Resources

3 Resources for

chris fernandez and internet

eHealth: Steady as She Goes: Chris Fernandez submits: It’s been a rather quiet quarter for eHealth, Inc. (NASDAQ: EHTH), the nation’s leading online source of health insurance for individuals, families and small businesses. With their upcoming earnings for Q1/2009 set to be released after the market closes on April 28th, we’ll be able...; Tags: Internet, Chris Fernandez, eHealth Inc.; External links 2009-04-23
eHealth Q1: Continues to Execute Well, Remains Top Pick: Chris Fernandez submits:eHealth (NASDAQ: EHTH), the leading provider of Internet-based insurance agency services to individuals, families, and small businesses primarily in the United States, announced solid Q1/09 results after the market closed Tuesday. As I had previously written about in my eHealth earnings preview, the company did exactly as...; Tags: Internet, Chris Fernandez, eHealth Inc.; External links 2009-04-30
eHealth Earnings: A Beacon of Light In a Tumultuous Market: Chris Fernandez submits: eHealth (NASDAQ: EHTH), the leading provider of Internet-based insurance agency services to individuals, families, and small businesses primarily in the United States, announced solid Q4 and full year 2008 earnings after the market closed tonight. Everything from customer acquisition costs, to cash flow generation, to forward guidance...; Tags: Internet, Chris Fernandez, eHealth Inc.; External links 2009-02-13

eHealth: Still Solid Despite the Economy: Chris Fernandez submits: eHealth (NASDAQ: EHTH), the leading provider of Internet-based insurance agency services to individuals, families, and small businesses primarily in the United States, recently announced their Q3/2008 earnings on October 30th. While it appears eHealth is seeing some of the same headwinds that are affecting other businesses,...; Tags: Seeking Alpha, Chris Fernandez, E-health, Healthcare, eHealth Inc.; External links 2008-11-06
Eli Lilly Q2 2007 Earnings Call Transcript: Question-and-Answer SessionOperator Operator Instructions And our first question comes from the line of James Kelly of Goldman Sachs. Please go ahead. James Kelly - Goldman Sachs Thank you and good morning. My question relates to Zyprexa and the depot formulation, and thank you for the additional data in Canada...; Tags: Eli Lilly & Co.; Earnings calls 2007-07-24